Cargando…

Risk Factors in Neuroleptic Malignant Syndrome

Neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious idiosyncratic response to neuroleptic antipsychotics. It usually affects young males, but the risk has been seen to increase with certain factors including the administration practices of antipsychotic neuroleptics in these...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Vinay, Magon, Rakesh, Mishra, B.P., Sidhu, G.B.S., Mahajan, Ranjiv
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951537/
https://www.ncbi.nlm.nih.gov/pubmed/21206810
_version_ 1782187710119673856
author Gupta, Vinay
Magon, Rakesh
Mishra, B.P.
Sidhu, G.B.S.
Mahajan, Ranjiv
author_facet Gupta, Vinay
Magon, Rakesh
Mishra, B.P.
Sidhu, G.B.S.
Mahajan, Ranjiv
author_sort Gupta, Vinay
collection PubMed
description Neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious idiosyncratic response to neuroleptic antipsychotics. It usually affects young males, but the risk has been seen to increase with certain factors including the administration practices of antipsychotic neuroleptics in these individuals. Even though no predictors for NMS are yet known, this article highlights the findings on certain risk factors as seen from a series of fifteen patients who developed NMS. Cautious use of neuroleptics in those at risk, early recognition and institution of immediate management is important.
format Text
id pubmed-2951537
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29515372011-01-04 Risk Factors in Neuroleptic Malignant Syndrome Gupta, Vinay Magon, Rakesh Mishra, B.P. Sidhu, G.B.S. Mahajan, Ranjiv Indian J Psychiatry Original Article Neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious idiosyncratic response to neuroleptic antipsychotics. It usually affects young males, but the risk has been seen to increase with certain factors including the administration practices of antipsychotic neuroleptics in these individuals. Even though no predictors for NMS are yet known, this article highlights the findings on certain risk factors as seen from a series of fifteen patients who developed NMS. Cautious use of neuroleptics in those at risk, early recognition and institution of immediate management is important. Medknow Publications 2003 /pmc/articles/PMC2951537/ /pubmed/21206810 Text en Copyright: © Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Gupta, Vinay
Magon, Rakesh
Mishra, B.P.
Sidhu, G.B.S.
Mahajan, Ranjiv
Risk Factors in Neuroleptic Malignant Syndrome
title Risk Factors in Neuroleptic Malignant Syndrome
title_full Risk Factors in Neuroleptic Malignant Syndrome
title_fullStr Risk Factors in Neuroleptic Malignant Syndrome
title_full_unstemmed Risk Factors in Neuroleptic Malignant Syndrome
title_short Risk Factors in Neuroleptic Malignant Syndrome
title_sort risk factors in neuroleptic malignant syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951537/
https://www.ncbi.nlm.nih.gov/pubmed/21206810
work_keys_str_mv AT guptavinay riskfactorsinneurolepticmalignantsyndrome
AT magonrakesh riskfactorsinneurolepticmalignantsyndrome
AT mishrabp riskfactorsinneurolepticmalignantsyndrome
AT sidhugbs riskfactorsinneurolepticmalignantsyndrome
AT mahajanranjiv riskfactorsinneurolepticmalignantsyndrome